Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
NovioTech BV   Technology to the MarketFrom Glucose Sensor to Hydrogel      Hans Hanssen (CTO)  Presented 30 June 2011 to ...
About NovioTech BV• Shareholders:     •   Tweehuysen Holding BV     •   Hanssen Investment and Consultancy BV     •   Prof...
About the Speaker:       Hans Hanssen• Former CEO of MCTEC• Co-Founder of DSE BV, Eyetube BV, MCTEC BV,  NovioTech BV• Bus...
Outline of the Talk• NovioSense – Glucose Sensor Technology• NovioHelix – Novel Thermogel Technology
Diabetes•   At this moment World Health Organization estimates 5-7% of the worldpopulation    has diabetes.•   This will i...
Standard sensors• Involves finger-pricking for sampling• Not-continuous monitoring
Concept sensor            A                            V                                            Electrochemical reacti...
9.00E-07                              y = 5.36E-07x + 2.10E-07               8.00E-07            R2 = 9.96E-01            ...
Semi-Continuous Glucose Monitoring   Sending signal to   receiver in glassesAmplifying signal andtransmition to insulin pump
Project StatusPatent Pending: NovioTech AssigneeContact with Major Players in the Glucose Management IndustryRaised €1.1M ...
Warm                          CoolGel formation at up to 99.98% waterProgrammable transition temperaturesOptically Transpa...
Market Opportunities Based on Bulk Properties
Low Hanging Fruit: NanoWipe            Contacts with Potential End Users (DSM Resolve) and Instrument            Manufactu...
3D Tissue Culture Medium
Wound Care
Project StatusIdentified Dedicated Project ManagerPatent Pending: NovioTech has Exclusive LicensePromising New Thermo Resp...
Wound Management
Novio tech - hans hanssen 30062011
Novio tech - hans hanssen 30062011
Novio tech - hans hanssen 30062011
Novio tech - hans hanssen 30062011
Novio tech - hans hanssen 30062011
Novio tech - hans hanssen 30062011
Novio tech - hans hanssen 30062011
Upcoming SlideShare
Loading in …5
×

Novio tech - hans hanssen 30062011

1,435 views

Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Novio tech - hans hanssen 30062011

  1. 1. NovioTech BV Technology to the MarketFrom Glucose Sensor to Hydrogel Hans Hanssen (CTO) Presented 30 June 2011 to Valorisation UMC Radboud
  2. 2. About NovioTech BV• Shareholders: • Tweehuysen Holding BV • Hanssen Investment and Consultancy BV • Prof. Jan van Hest • Prof. Alan Rowan • Scientific Advisor: Prof Roeland Nolte www.noviotech.com
  3. 3. About the Speaker: Hans Hanssen• Former CEO of MCTEC• Co-Founder of DSE BV, Eyetube BV, MCTEC BV, NovioTech BV• Business Advisor to EPFlex GmBH, Nano4Imaging BV, Encapson BV
  4. 4. Outline of the Talk• NovioSense – Glucose Sensor Technology• NovioHelix – Novel Thermogel Technology
  5. 5. Diabetes• At this moment World Health Organization estimates 5-7% of the worldpopulation has diabetes.• This will increase within the next 20 years to 300 million.• Diabetes can lead to: – Heart disease and stroke – High blood pressure – Blindness – Kidney disease – Nervous system disease (Neuropathy) – Amputation
  6. 6. Standard sensors• Involves finger-pricking for sampling• Not-continuous monitoring
  7. 7. Concept sensor A V Electrochemical reactions E°/V WE: H2O2  2H+ + O2 + 2e- 0.695Counter Working Reference CE: 2H+ + ½O2 + 2e-  H2OElectrode Electrode Electrode RE: Ag(s) + Cl-  AgCl(s) 0.22233
  8. 8. 9.00E-07 y = 5.36E-07x + 2.10E-07 8.00E-07 R2 = 9.96E-01 7.00E-07 6.00E-07Current (A) 5.00E-07 4.00E-07 3.00E-07 2.00E-07 1.00E-07 0.00E+00 0 0.5 1 Glucose conc. (mM) The resulting current is linear within the concentration regime of glucose levels in tear fluid
  9. 9. Semi-Continuous Glucose Monitoring Sending signal to receiver in glassesAmplifying signal andtransmition to insulin pump
  10. 10. Project StatusPatent Pending: NovioTech AssigneeContact with Major Players in the Glucose Management IndustryRaised €1.1M of Inter Regional FundingGoal is Functional Prototypes in 12 Months From Now
  11. 11. Warm CoolGel formation at up to 99.98% waterProgrammable transition temperaturesOptically TransparentBiocompatibleForms Nano-Pores (100-250nm)Stiffness from (10 - 1000Pa)
  12. 12. Market Opportunities Based on Bulk Properties
  13. 13. Low Hanging Fruit: NanoWipe Contacts with Potential End Users (DSM Resolve) and Instrument Manufacturers (NanoSight UK)
  14. 14. 3D Tissue Culture Medium
  15. 15. Wound Care
  16. 16. Project StatusIdentified Dedicated Project ManagerPatent Pending: NovioTech has Exclusive LicensePromising New Thermo Responsive Nano MaterialIdentify Most Promising Market AreasEarly Prototype NanoWipeProof of Principle BioMedical Applications Underway
  17. 17. Wound Management

×